Exploration Of Metabolites Research Articles

Quality Standards and Pharmacological Interventions of Natural Oils: Current Scenario and Future Perspectives.

Medicinal plants are rich sources of natural oils such as essential and fixed oils used traditionally for nutritive as well as medicinal purposes. Most of the traditional formulations or phytopharmaceutical formulations contain oil as the main ingredient due to their own therapeutic applications and thus mitigating several pathogeneses such as fungal/bacterial/viral infection, gout, psoriasis, analgesic, antioxidant, skin infection, etc. Due to the lack of quality standards and progressive adulteration in the natural oils, their therapeutic efficacy is continuously deteriorated. To develop quality standards and validate scientific aspects on essential oils, several chromatographic and spectroscopic techniques such as HPTLC, HPLC, NMR, LC-MS, and GC-MS have been termed as the choices of techniques for better exploration of metabolites, hence sustaining the authenticity of the essential oils. In this review, chemical profiling and quality control aspects of essential or fixed oils have been explored from previously reported literature in reputed journals. Methods of chemical profiling, possible identified metabolites in essential oils, and their therapeutic applications have been described. The outcome of the review reveals that GC-MS/MS, LC-MS/MS, and NMR-based chromatographic and spectroscopic techniques are the most liable, economic, precise, and accurate techniques for determining the spuriousness or adulteration of oils based on their qualitative and quantitative chemical profiling studies. This review occupies the extensive information about the quality standards of several oils obtained from natural sources for their regulatory aspects via providing the detailed methods used in chemoprofiling techniques. Hence, this review helps researchers in further therapeutic exploration as well as quality-based standardization for their regulatory purpose.

Detection of actinobacteria from sediment soil: Exploration of metabolites as fungal plant pathogen inhibitors and plant growth promoters

The rhizosphere is an area with dense microbial activity. Actinobacteria are one among the rhizomicroflora inhabiting in the plant rhizosphere by protecting plants from pathogens by producing secondary metabolites, as plant growth promoters and by producing hydrolytic enzymes. But in the modern era of agriculture, the outrageous use of chemical fertilizers in the agriculture fields is causing major environmental pollution and the agricultural soil is losing its texture and fertility. So, in the present study, we aimed to isolate and screen indigenous actinobacterial strains which are capable of producing antifungal metabolites, plant growth promoting ability and hydrolytic enzymes. A total of 23 isolates of actinobacteria have been isolated. Among all the other actinobacterial isolates, Streptomyces sp. DRPG-15, which was isolated from the sediment soil of the Tamankal River, revealed a noticeable antagonistic activity against Macrophomina phaseolina for Sorghum and Sclerotium rolfsii for Chickpeas respectively. 16S rRNA sequence analysis showed that the Streptomyces sp. DRPG-15 exhibited 100% homology with Streptomyces enissocaesilis DRPG-15 OP985046. All 23 isolates were screened for the production of indole acetic acid, hydrogen cyanide, ammonia production and nitrate reduction and were also screened for various hydrolytic enzymes like Caseinase, Protease, Cellulase, Amylase, Chitinase, Pectinase, Gelatinase, L-asparaginase and Streptomyces sp. DRPG-15 was the only isolate that showed positive results for antagonistic activity, plant growth-promoting ability and enzymatic activity. The entire study indicates that the selected strain of Streptomyces sp. DRPG-15 is implying its possible utilization as a natural bioinoculant for sustainable agriculture.

Coronavirus disease 2019 (COVID-19) update: From metabolic reprogramming to immunometabolism.

The field of immunometabolism investigates and describes the effects of metabolic rewiring in immune cells throughout activation and the fates of these cells. Recently, it has been appreciated that immunometabolism plays an essential role in the progression of viral infections, cancer, and autoimmune diseases. Regarding COVID‐19, the aberrant immune response underlying the progression of diseases establishes two major respiratory pathologies, including acute respiratory distress syndrome (ARDS) or pneumonia‐induced acute lung injury (ALI). Both innate and adaptive immunity (T cell‐based) were impaired in the course of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. Current findings have deciphered that macrophages (innate immune cells) are involved in the inflammatory response seen in COVID‐19. It has been demonstrated that immune system cells can change metabolic reprogramming in some conditions, including autoimmune diseases, cancer, and infectious disease, including COVID‐19. The growing findings on metabolic reprogramming in COVID‐19 allow an exploration of metabolites with immunomodulatory properties as future therapies to combat this hyperinflammatory response. The elucidation of the exact role and mechanism underlying this metabolic reprograming in immune cells could help apply more precise approaches to initial diagnosis, prognosis, and in‐hospital therapy. This report discusses the latest findings from COVID‐19 on host metabolic reprogramming and immunometabolic responses.